AbbVie
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
AbbVie (ABBV) Business News
Track AbbVie in real time with a live news feed covering AbbVie stock news, official press releases, company announcements, and an archive of historical AbbVie news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Got $500? 2 Pharma Stocks to Buy and Hold Forever.
AbbVie Inc. (ABBV) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript
54 Stocks, 9 Megatrends: My Favorite Places To Be While Capital Is 'Forced'
1 Reason I'm Never Selling AbbVie Stock
AbbVie sues US health agency over Botox price controls
Abbvie sues US health agency over Botox
2 Urgent Sells And 2 No Brainer Dividend Buys
Here's Why AbbVie (ABBV) is a Strong Value Stock
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
8:15 AM | Saturday | Feb 14, 2026
Markets are choppy in 2026, and many investors believe we could see a correction this year. Investors should be prepared with defensive stocks that generate reliable dividends.
Read full article
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
The Motley FoolMarkets are choppy in 2026, and many investors believe we could see a correction this year. Investors should be prepared with defensive stocks that generate reliable dividends.
Read full article
Got $500? 2 Pharma Stocks to Buy and Hold Forever.
The Motley FoolStocks in the healthcare sector can often serve as a hedge against broader market volatility. But there are also some high-flying growth stocks, particularly within the pharmaceutical and biotech industries.
Read full article
AbbVie Inc. (ABBV) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript
Seeking AlphaAbbVie Inc. (ABBV) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript
Read full article
54 Stocks, 9 Megatrends: My Favorite Places To Be While Capital Is 'Forced'
Seeking AlphaMy top-down strategy targets 'mission-critical' sectors where capital is forced by secular and cyclical tailwinds—data centers, energy, AI, defense, and infrastructure. AI-driven data center and energy spending, defense modernization, and industrial reshoring are creating robust, non-cyclical investment opportunities across select equities. I highlight actionable picks in each segment, including VRT, VST, QXO, MU, TMO, RTX, RACE, MA, CAT, FCX, and key midstream energy names.
Read full article
1 Reason I'm Never Selling AbbVie Stock
The Motley FoolAbbVie has proven its ability to adapt to changes and challenges and continue to thrive. This ability to evolve is arguably the most important trait for a company to possess.
Read full article
AbbVie sues US health agency over Botox price controls
ReutersAbbVie sued the U.S. Department of Health and Human Services on Wednesday, challenging a decision by the Centers for Medicare & Medicaid Services to impose price controls for Botox.
Read full article
Abbvie sues US health agency over Botox
ReutersAbbvie sued the U.S. Department of Health and Human Services on Wednesday, challenging a decision by the Centers for Medicare & Medicaid Services to select Botox for prescription drug price controls established by the federal Inflation Reduction Act of 2022.
Read full article
2 Urgent Sells And 2 No Brainer Dividend Buys
Seeking AlphaOne thing I've learned is the pendulum always swings. It is in our best approach to sell high and buy low. This has worked well for us, as our returns suggest.
Read full article
Here's Why AbbVie (ABBV) is a Strong Value Stock
Zacks Investment ResearchWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks Investment ResearchRecently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Read full article